FIELD: biochemistry, enzymology. SUBSTANCE: invention proposes the use of derivatives of benzotetrazine-1,3-dioxide of the general formula (I) given in description where R1 - H and R2 is NO2 or R1 is NO2 and R2 is H or NO2 that are used as activators of guanylate cyclase soluble form. Derivatives of benzotetrazine- -1,3-dioxide of the general formula (I) show an activating effect on guanylate cyclase soluble form and this effect is more expressed as compared with that of prototype. Invention can be used for study of mechanism of regulation of guanylate cyclase soluble form activity. EFFECT: broadened pattern of assortment of specific regulating agents. 1 ex
Title | Year | Author | Number |
---|---|---|---|
ACTIVATOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1997 |
|
RU2122582C1 |
DONOR OF NITROGEN OXIDE AND ACTIVATOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1997 |
|
RU2123046C1 |
(1,2,3-TRIAZOLYL)-1,2,3-OXADIAZOLE DERIVATIVES POTENTIATING NO-DEPENDENT ACTIVATION OF SOLUBLE FORM OF GUANYLATE CYCLAZE | 2000 |
|
RU2158265C1 |
DERIVATIVES OF TETRAFURAZANO-[3,4-B:3',4'-F:3'',4''-J:3''',- -4'''-N]-[1,4,5,8,9,12,13,16]-OCTAAZABICYCLO-[14,2,2]-EICOSA- -4,8,12-TRIENE AND METHOD OF THEIR SYNTHESIS | 2000 |
|
RU2167161C1 |
SPECIFIC REGULATOR OF ACTIVITY OF NUCLEOTIDE-DEPENDENT ENZYMES | 1997 |
|
RU2130490C1 |
DONOR OF NITROGEN OXIDE AND ACTIVATOR OF SOLUBLE FORM OF GUANYLATE CYCLASE | 1998 |
|
RU2139932C1 |
1,2,5-OXADIAZOLO[3,4-D]PYRIDAZINE-5,6-DIOXIDE DERIVATIVES AS ACTIVATORS OF SOLUBLE FORM OF GUANYLATE-CYCLASE AND AGENTS ACTIVE IN TREATMENT OF CENTRAL NERVOUS SYSTEM, AND COMPOSITIONS BASED ON THESE COMPOUNDS | 1997 |
|
RU2165256C2 |
IRREVERSIBLE INHIBITOR OF [H, K]-ADENOSINE TRIPHOSPHATASE | 2001 |
|
RU2186108C1 |
PLATELET AGGREGATION INHIBITOR SHOWING ANTIMETASTATIC EFFECT | 2001 |
|
RU2192857C1 |
DERIVATIVES OF 1,4,2,5-DIOXADIAZINE | 2001 |
|
RU2212409C1 |
Authors
Dates
1998-12-20—Published
1997-12-26—Filed